1. Adams LM, Geyer MA (1985) Patterns of exploration in rats distinguishes lisuride from lysergic acid diethylamide. Pharmacol Biochem Behav 23: 461–468
2. Agnoli A, Ruggieri S, Baldassarre M, Stocchi F, Denaro A, Falaschi P (1983) Dopaminergic ergots in Parkinsonism. In: Calne DB, Horowski R, McDonald RJ, Wuttke W (eds). Lisuride and other dopamine agonists. Raven, New York, pp 407–417
3. Ahlenius S, Larsson K, Svensson L (1980) Stimulating effects of lisuride on masculine sexual behaviour. Eur J Pharmacol 64: 47–51
4. Aizawa T, Kutsuzawa T, Otomo E, Goto F, Tazaki Y, Abe H, Omae T, Kameyama M, Ito H (1980) Clinical utility of eunal in treatment of cerberovascular disorders: multi-center double-blind study in comparison with dihydroergotoxine mesylate. Clin Eval 8: 577–628
5. Albizzati MG, Alemani A, Bassi G, Ferrarese C, Frattola L, Trabucchi M (1982) Effetti del lisuride nella patologia discinetico distonica: Considerazioni patogenetiche. In: Agnoli A, Bertolani G (eds) Morbo di Parkinson e compromissione delle attivita’ nervose superiori. 8th Meeting LIMPE, Rome, 31 Oct 1981. Guanelli, Rome, pp 223–231